Indonesian digital pharmacy Lifepack scores $7M in Sequence A funding
Lifepack, a digital pharmacy in Indonesia, has raised $7 million in a Sequence A funding spherical led by Golden Gate Ventures.
Launched in 2020, the cell well being platform provides high quality and low cost medicines, together with over-the-counter medicine, common dietary supplements, and drugs for continual sicknesses. Accessible on Android and iOS gadgets, Lifepack additionally supplies on-demand on-line session from registered docs and a workforce of licensed pharmacists.
In accordance with a news report, its contemporary funds will go to constructing seven extra pharmacy warehouses throughout Indonesia, including to its current two warehouses in Jakarta and Surabaya.
CureApp indicators license take care of Sawai Group for upcoming NASH DTx app
Japanese medical expertise firm CureApp is getting an funding value as much as 10.5 billion yen ($77 million) as a part of a newly signed take care of the pharmaceutical agency Sawai Group.
The license settlement will present the Sawai Group unique rights for the event and advertising and marketing of a brand new digital therapeutics app for the therapy of non-alcoholic steatohepatitis (NASH), a sophisticated type of non-alcoholic fatty liver illness.
CureApp notes that there are some two million sufferers with NASH in Japan immediately with 10 million extra who’re vulnerable to growing the illness.
Its upcoming DTx app will present customers with a personalised each day behaviour remedy routine and a visible information of their therapy standing.
The corporate plans to roll out the app in medical establishments through its proprietary app prescription service. Presently, CureApp is making ready to enter the third section of scientific trials of the NASH DTx app.
Wipro GE Healthcare ties up with Boston Scientific for mixed coronary heart care choices in India
Medical expertise firm Wipro GE Healthcare and Boston Scientific, a US-based medical system producer, have entered right into a collaboration to ship end-to-end interventional cardiac care options in India.
Boston Scientific will mix its medical gadgets with GE Healthcare’s medical imaging programs, significantly its cardiac catheterisation lab and associated software program, to assist diagnostics by means of therapy and monitoring of the cardiac patient-care pathway.
The organisations will even assist the coaching and training of healthcare professionals and can increase shopper consciousness concerning the improvements in cardiac catheterisation procedures.
The same collaboration that provides their mixed cardiology options has additionally kicked off in Southeast Asia.
Psychological well being app Mind helps Banyan Tree’s wellness programme
Digital psychological well being platform Mind has partnered with multinational hospitality group Banyan Tree to assist the latter’s wellbeing programme.
Friends who’ve booked the Wellbeing Sanctuary service at Banyan Tree Bintan in Indonesia could have entry to the Mind cell app as a part of an end-to-end wellbeing assist bundle.
From August, guided content material and habit-building packages from the Mind app will probably be made accessible for visitors to entry all through and after their keep.
AstraZeneca to ship Alveofit’s IoT-powered spirometers throughout Indian care settings
AstraZeneca India has teamed up with digital respiratory care platform Alveofit to ship IoT-enabled spirometers throughout its community of care settings in India.
In accordance with a press assertion, the Alveofit gadgets will probably be used to remotely monitor the situations of sufferers with lung issues and related non-communicable illnesses like bronchial asthma, pulmonary fibrosis and continual obstructive pulmonary illness.
Will probably be distributed in choose hospitals underneath AstraZeneca’s A.Catalyst community, which incorporates Worker’s State Insurance coverage Corp. hospitals, command and navy hospitals, common hospitals and final mile clinics in cities equivalent to Lucknow, Chennai, Nagpur, Delhi, Ahmedabad and Kolkata.